Reports

7498 Results (Page 62 of 300)

Pharmaceuticals Markets Research Reports

Pharmaceuticals

Mexico Migraine Drugs Market Analysis

Mexico migraine drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. High alcohol consumption, rising healthcare costs, rising job stress, and rising medicine demand are all expected to drive market expansion. In the years ahead, it is anticipated that there will be a rise in public knowledge of migraines and available treatments which will further act as a driver for Migraine Drugs Market. The major key players in this market are Amgen, Abbott Laboratories, Allergan, Eli Lilly, Pfizer, Inc., AstraZeneca, Johnson and Johnson Services, Inc., and GlaxoSmithKline.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Philippines Tetanus Toxoid Vaccine Market Analysis

Philippines Tetanus Toxoid Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Tetanus toxoid vaccine market is growing globally due to the government initiatives like mandatory immunization programs, increasing awareness among individuals and healthcare professionals about the importance of tetanus vaccination, improved healthcare infrastructure which has facilitated the distribution and administration of tetanus toxoid vaccines, technological advancements in vaccine manufacturing techniques including improved purification methods and rising Incidence of tetanus cases. Sanofi Pasteur, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech, Biological E. Limited are the key global market players in tetanus toxoid vaccine market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Singapore Gastroesophageal Reflux Disease (GERD) Drugs Market Analysis

Singapore Gastroesophageal Reflux Disease (GERD) Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The high prevalence of GERD, rising awareness and diagnostic rates, technology improvements, and lifestyle variables are all driving factors in the Gastroesophageal Reflux Disease (GERD) medications market. Some prominent global players in the Gastroesophageal Reflux Disease (GERD) drugs market include AstraZeneca PLC, Pfizer Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson, GlaxoSmithKline plc, Eli Lilly and Company, AbbVie Inc., Mylan N.V., Perrigo Company plc, and Sun Pharmaceutical Industries Ltd.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Oral Anti-Diabetes Drugs Market Analysis

South Africa oral anti-diabetes drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Due to the rise in type 2 diabetes incidence, the market for oral antidiabetic medications is anticipated to have a considerable increase over the forecast period. The adoption of a bad lifestyle, environmental pollution, and a family history of diabetes disease all contribute to the market growth for oral antidiabetic medications. Some of the major key players in this market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Mylan N.V., Fresenius Kabi AG, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Spain Unresectable Hepatocellular Carcinoma Market Analysis

Spain Unresectable Hepatocellular Carcinoma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Unresectable Hepatocellular Carcinoma market is growing globally due to the increasing incidence of unresectable hepatocellular carcinoma which is mainly due to rise in risk factors such as chronic hepatitis B and C infections, alcohol abuse, non-alcoholic fatty liver disease (NAFLD), and obesity. Advancements in diagnostic techniques like imaging techniques and biopsy, introduction of targeted therapies, immunotherapies, rising emphasis on combination therapies, clinical Trials and research initiatives. Bayer AG, Bristol Myers Squibb Company, Eisai Co., Ltd., Exelixis, Inc., Ipsen Pharma, Merck & Co., Inc., Novartis International AG, Roche Holding AG, Sanofi S.A., Takeda Pharmaceutical Company Limited are the key global market players in unresectable hepatocellular carcinoma market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

UK Head and Neck Cancer Drugs Market Analysis

UK Head and Neck Cancer Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the head and neck cancer drugs market in the USA include the increasing incidence of head and neck cancer, advancements in treatment options, rising demand for personalized medicine, and supportive government initiatives. Global Companies in Head and Neck Cancer Drugs Market are Bristol Myers Squibb Company, Merck & Co., Inc., Pfizer Inc., AstraZeneca plc, Novartis AG, Eli Lilly and Company, Amgen Inc., GlaxoSmithKline plc, Johnson & Johnson, Sanofi, Roche Holding AG, Takeda Pharmaceutical Company Limited, Bayer AG, AbbVie Inc. and Eisai Co., Ltd.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

US PEGylated Proteins Market Analysis

US PEGylated Proteins market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for PEGylated Proteins is growing rapidly as a result of the growing incidence and prevalence of degenerative & chronic diseases like cancer, kidney diseases, and rheumatoid arthritis. Thermo Fisher Scientific Inc., Merck KGaA, NOF Corporation, Jenkem Technology, etc., are some of the key players in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Inhaled Nitric Oxide Market Analysis

China inhaled nitric oxide market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The factors driving the growth of this market are the rising prevalence of respiratory and other associated diseases and ongoing research and development activities. The key players in this market are Mallinckrodt, Linde plc., Air Liquide, BOC Limited, Bellerophon Therapeutics, Beyond Air Inc., Halma plc, VERO Biotech, Nu-Med Plus, Getinge AB, Merck KGaA, Genosys Informatics, Geno, and Perma Pure LLC.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Precision Medicine Market Analysis

Egypt Precision Medicine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Precision Medicine market is growing globally due to the advancements in genomics and molecular biology, increasing adoption of personalized therapies, rising prevalence of chronic diseases, the promise of improved patient outcomes, increasing rate of CNS Disorders such as Alzheimer's disease, epilepsy, multiple sclerosis, increasing partnerships between market players and higher technological advancements of precision medicine. Moderna, Inc., Personalis, Inc., CureVac SE, Celldex Therapeutics, BioNTech SE, Advaxis, Inc., Agenus Inc., Immatics Biotechnologies GmbH, Gritstone Oncology, ImmunityBio, Inc., bioMérieux SA, Bayer AG, Pfizer Inc., GSK plc, F. Hoffmann-La Roche Ltd. are the key market players involved in precision medicine market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Germany Chondroitin Market Analysis

Germany Chondroitin Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for chondroitin is driven by factors such as the increasing prevalence of musculoskeletal disorders and osteoarthritis, the growing aging population, rising consumer awareness about the benefits of natural and alternative therapies, and the demand for effective and safe solutions for joint health. Synutra Pure Ltd., TSI Group Ltd. Bioiberica S.A.U., Seikagaku Corporation, etc. are some of the global companies in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Indonesia Mammography Device Market Analysis

Indonesia mammography device market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The demand for mammography equipment is influenced by early cancer detection, cancer fear, and quality of life after a diagnosis. The major key players in this market are Hologic Inc., Analogic Corporation, Canon Medical Systems Corporation, Fujifilm Corporation, Siemens Healthcare, Toshiba Medical Systems, GE Healthcare, Metaltronica, Koninklijke Philips N.V., Planmed Oy.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Japan Rituximab Biosimilars Market Analysis

Japan Rituximab Biosimilars Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rituximab biosimilars market is growing globally due to the government initiatives, increased healthcare expenditure, increase in biopharmaceutical R&D expenditure, low cost of biosimilars, aging population, increase in healthcare access, patent expiry of reference product, rising prevalence of chronic diseases and growing acceptance and confidence for biosimilars. Teva Pharmaceuticals, Novartis AG, Pfizer, BIOCAD, and Shanghai Henlius Biotech, Inc. are the key global market players in Rituximab Biosimilars Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Diabetic Retinopathy Drugs Market Analysis

Malaysia Diabetic Retinopathy Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing prevalence of diabetic retinopathy, technological advancements in drug development, growing awareness and screening programmes, the ageing population, and government initiatives to improve access to screening and treatment for diabetic retinopathy are the drivers of the Diabetic Retinopathy Drugs market. Novartis AG, Regeneron Pharmaceuticals, Allergan plc (part of AbbVie Inc.), Roche Holding AG, Pfizer Inc., Bayer AG, Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Bausch Health Companies Inc., Alimera Sciences, are key global companies in diabetic retinopathy drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Multiple Myeloma Drugs Market Analysis

Mexico multiple myeloma drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased prevalence of the illness, new technologies, and improved healthcare systems are a few of the elements boosting the revenue of the worldwide multiple myeloma market. The major key players in this market are Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Genentech Inc. (F. Hoffmann-La Roche Ltd), Novartis AG, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Philippines Thin Film Drugs Market Analysis

Philippines Thin Film Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Thin Film Drugs market is growing globally due to the pediatric and geriatric applications as they have difficulty in swallowing conventional tablets, technological advancements like development of innovative film-forming materials, improved manufacturing processes and enhanced drug delivery systems, better patient convenience and compliance thereby improving medication adherence, rapid drug absorption and improved bioavailability and increase in research and development activities. Pfizer Inc., Novartis AG, GlaxoSmithKline plc (GSK), Johnson & Johnson Services, Inc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Aquestive Therapeutics, Inc., Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp., ZIM Laboratories Ltd., Indivior PLC, MonoSol Rx (A Subsidiary of MonoSol LLC), LTS Lohmann Therapie-Systeme AG, APR Applied Pharma Research s.a., CURE Pharmaceutical Holding Corp. are the key global market players in thin film drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Singapore Gastrointestinal Drugs Market Analysis

Singapore Gastrointestinal Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of gastrointestinal problems, caused by factors such as changing lifestyles, dietary habits, and an ageing population, is one of the main drivers for gastrointestinal medications. Technological advances in drug research and targeted medicines, which provide more effective treatment alternatives, also contribute to market growth. Furthermore, as people become more aware of and diagnose gastrointestinal diseases, the need for medications to treat these conditions grows. Pfizer Inc., Johnson & Johnson, AbbVie Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, GlaxoSmithKline plc, Bristol Myers Squibb Company, Eli Lilly and Company, Merck & Co., Inc., and Allergan plc are among the major global competitors in the gastrointestinal drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Oral Care Market Analysis

South Africa Oral Care Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030.The global increase in dentists in practise, the prevalence of dental illnesses, and technological developments in oral care products are the key drivers of the oral care market. The global Oral Care market’s major key players are Church and Dwight Co. Inc., Lion Corporation, Dentaid, GlaxoSmithKline, Procter and Gamble, Real Teeth Dental Clinic, Roomchang Dental Hospital, Pachem Dental Clinic, Sunstar Suisse S.A., Johnson and Johnson Consumer Inc., Dr. Fresh LLC, Colgate-Palmolive Company.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Spain Urothelial Carcinoma Market Analysis

Spain Urothelial Carcinoma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Urothelial Carcinoma market is growing globally due to the increasing incidence and prevalence of urothelial carcinoma due to aging population, smoking, exposure to certain chemicals, and chronic bladder inflammation, advancements in diagnostic techniques like urinary biomarkers, cystoscopy, development of novel therapies like targeted therapies or immune checkpoint inhibitors and increased focus on personalized medicine. AstraZeneca PLC, Bristol Myers Squibb Company, Eli Lilly and Company, Genentech, Inc. (a member of the Roche Group), Merck & Co., Inc., Novartis AG, Pfizer Inc., Seattle Genetics, Inc., Sanofi S.A., Johnson & Johnson are the key global market players in urothelial carcinoma market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

UK Heart Failure Drugs Market Analysis

UK Heart Failure Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The drivers of the heart failure drugs market include the increasing prevalence of heart failure, the aging population, advancements in drug therapies, rising awareness and diagnosis, and supportive government initiatives. Novartis AG, Pfizer Inc., AstraZeneca plc, Johnson & Johnson, Merck & Co., Bristol Myers Squibb Company, Boehringer Ingelheim International GmbH, Bayer AG, GlaxoSmithKline plc and Amgen are global key players in Heart Failure Drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

US Peptic Ulcer Drugs Market Analysis

US Peptic ulcer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for peptic ulcer drugs is growing rapidly as a result of the rising incidence and prevalence of peptic ulcer disease due to increasing alcohol and tobacco consumption, increasing stress levels, and the prevalence of Helicobacter pylori (a common bacteria associated with peptic ulcers), increasing investment in healthcare infrastructure, increasing adoption of over the counter drugs, increase in research and development activities and a strong pipeline for new drugs also contribute to the market growth. Allergan, AstraZeneca, Johnson & Johnson Private Limited, Hikma Pharmaceuticals PLC, etc. are some of the key this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Canada Blood Plasma Market Analysis

Canada Blood Plasma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rising demand for plasma-derived therapies, advancements in plasma fractionation technologies, rising awareness and adoption of plasma-derived therapies, a favourable regulatory environment, increased investment in plasma collection centres, and a growing need for blood plasma in research and development are key drivers in the blood plasma market. CSL Behring, Grifols, Octapharma, Biotest AG, and Kedrion are some of the major global competitors in the blood plasma industry.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Interactive Wound Dressing Market Analysis

China interactive wound dressing market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Technology improvements, a growth in the prevalence of chronic wounds, and an increase in surgical procedures are the main factors driving the market for interactive wound dressings. Some of the key players in this market are Johnson & Johnson Medical N.V., Integra LifeSciences Corporation, B. Braun Melsungen AG, Cardinal Health, Medline Industries, Inc., Coloplast Pty Ltd, Medtronic, Beiersdorf AG, Mölnlycke Health Care AB, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Pressure Sensor Market Analysis

Egypt Pressure Sensor Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Pressure Sensor market is growing globally due to the rising demand from sectors like consumer electronics, healthcare, automotive, improvements in sensor technology, expanding use of automation, IoT applications, growing demand for pressure sensors in domestic appliances like refrigerators and washing machines. Use of pressure sensors in smartphones, increase in remote connectivity, and advancements in nanoelectromechanical system (NEMS) technology. Fuji Electric Co., Omron Corporation, Broadcom, Panasonic, Infineon Technologies AG, Honeywell International Inc., Siemens, Hitachi automotive system Ltd., Emerson Electric Co., ABB, NXP Semiconductors, STMicroelectronics, Sensata Technologies, Inc., Robert Bosch GmbH, TE Connectivity, Oxensis, Schneider Electric SE, and Baumer are the key global market players in pressure sensor market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Germany Coenzyme Q10 Market Analysis

Germany Coenzyme Q10 Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The Coenzyme Q10 market can witness growth due to factors such as increased consumer awareness, rising demand for dietary supplements and functional foods, growing interest in anti-aging and cardiovascular health applications in healthcare, the aging population, rising health consciousness, and product innovation. Prominent global players in the Coenzyme Q10 (CoQ10) market include Kaneka Corporation, DSM Nutritional Products, Hwail Pharmaceutical Co., Ltd., Tishcon Corporation, and Healthy Origins.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Indonesia Medical Cannabis Drugs Market Analysis

Indonesia medical cannabis drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Globally, there are more people with chronic illnesses, which will probably result in an increase in patients, and people are becoming more interested in living healthy lives. Additionally, it's projected that a rise in product approvals and increased R&D for cannabis-related medical devices will fuel market growth. The major key players in this market are Tilray, Bedrocan International, Canopy Growth Corporation, Aurora Cannabis Inc., Vivo Cannabis Inc., Maricann Inc., Medical Marijuana Inc., Organigram Holdings Inc., The Scotts Company LLC, Curaleaf Holdings, Inc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

subscribe to our newsletter
up